S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

リアルタイムの更新: Sosei Group Corporation [4565.T]

取引所: JPX セクター: Healthcare 産業: Biotechnology
Upcoming Earnings Alert

3 days till quarter result
(bmo 2024-05-08)

Expected move: +/- 0.00%

最終更新日時2 5月 2024 @ 15:15

1.67% ¥ 1 519.00

Live Chart Being Loaded With Signals

Commentary (2 5月 2024 @ 15:15):

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis...

Stats
本日の出来高 644 100
平均出来高 1.34M
時価総額 135.87B
EPS ¥-2.13 ( 2024-02-13 )
次の収益日 ( ¥35.75 ) 2024-05-08
Last Dividend ¥2.50 ( 2015-03-27 )
Next Dividend ¥0 ( N/A )
P/E -17.42
ATR14 ¥1.040 (0.07%)

ボリューム 相関

長: -0.14 (neutral)
短: -0.10 (neutral)
Signal:(53.491) Neutral

Sosei Group Corporation 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Sosei Group Corporation 相関 - 通貨/商品

The country flag -0.12
( neutral )
The country flag -0.19
( neutral )
The country flag -0.60
( weak negative )
The country flag -0.05
( neutral )
The country flag -0.43
( neutral )
The country flag 0.36
( neutral )

Sosei Group Corporation 財務諸表

Annual 2023
収益: ¥12.77B
総利益: ¥7.87B (61.62 %)
EPS: ¥-87.17
FY 2023
収益: ¥12.77B
総利益: ¥7.87B (61.62 %)
EPS: ¥-87.17
FY 2022
収益: ¥15.57B
総利益: ¥14.64B (94.05 %)
EPS: ¥4.67
FY 2021
収益: ¥17.71B
総利益: ¥16.78B (94.73 %)
EPS: ¥12.53

Financial Reports:

No articles found.

Sosei Group Corporation Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)

Sosei Group Corporation Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend ¥2.50 2015-03-27
Last Dividend ¥2.50 2015-03-27
Next Dividend ¥0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 1 --
Total Paid Out ¥2.50 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-05-05)
¥0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for JPX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
8084.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
7408.T Ex Dividend Junior 2024-03-28 Sporadic 0 0.00%
6629.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
5951.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
4641.T Ex Dividend Knight 2023-12-28 Semi-Annually 0 0.00%
3880.T Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%
3109.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
1982.T Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%
9994.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
8984.T Ex Dividend Knight 2023-08-30 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.5631.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.04581.200-1.525-1.830[0 - 0.3]
returnOnEquityTTM-0.1171.500-2.41-3.62[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM3.790.80010.008.00[1 - 3]
quickRatioTTM3.570.80010.008.00[0.8 - 2.5]
cashRatioTTM2.861.50010.0010.00[0.2 - 2]
debtRatioTTM0.445-1.5002.58-3.87[0 - 0.6]
interestCoverageTTM-3.341.000-2.35-2.35[3 - 30]
operatingCashFlowPerShareTTM-58.952.00-10.00-10.00[0 - 30]
freeCashFlowPerShareTTM-68.472.00-10.00-10.00[0 - 20]
debtEquityRatioTTM1.048-1.5005.81-8.71[0 - 2.5]
grossProfitMarginTTM0.6971.0001.7231.723[0.2 - 0.8]
operatingProfitMarginTTM-0.6921.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.07531.000-1.530-1.530[0.2 - 2]
assetTurnoverTTM0.08120.800-2.79-2.23[0.5 - 2]
Total Score-1.525

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-18.891.000-2.010[1 - 100]
returnOnEquityTTM-0.1172.50-1.551-3.62[0.1 - 1.5]
freeCashFlowPerShareTTM-68.472.00-10.00-10.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-58.952.00-10.00-10.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.3011.500-1.3260[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.4131.000-10.000[0.1 - 0.5]
Total Score-3.79

Sosei Group Corporation

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of HTL0022562, a calcitonin gene related peptide antagonist, which is in Phase I clinical study; HTL0016878 for neurological diseases; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; PF-07258669 for anorexia; and TMP301 and BHV3100 for neurological disorders, which is in clinical trials. Sosei Group Corporation has a strategic collaboration with AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, AstraZeneca, and Takeda. The company was incorporated in 1990 and is headquartered in Tokyo, Japan.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。